Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beckers

Showing results (231-240 of 255) with videos related to

Pageof 26
Sort By:
Clinical Endocrinology|December 24, 1997
Two years of replacement therapy in adults with growth hormone deficiencyJ Verhelst, R Abs, M Vandeweghe, et al.
Journal of the Neurological Sciences|March 1, 1992
The association of astrocytoma and pituitary adenoma in a patient with alcaptonuriaR Abs, M Van Vyve, P J Willems, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 23, 2016
GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone DeficiencyF Castinetti, A F Daly, C A Stratakis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patientsJ Verhelst, R Abs, D Maiter, et al.
Transfusion|December 2, 2017
The development of D antibodies after D-mismatched kidney transplantation in a setting of reduced immunosuppressionThomas H P M Habets, Joris Vanderlocht, Ron J M H E Straat, et al.
Clinical Endocrinology|April 18, 2003
Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiencyJ Svensson, J P Monson, T Vetter, et al.
Endocrine|April 26, 2020
The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) studyE C Coopmans, A Muhammad, A F Daly, et al.
Annales D'Endocrinologie|April 7, 2009
French consensus on the management of acromegalyP Chanson, J Bertherat, A Beckers, et al.
Endocrine|June 21, 2020
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey databaseV Amodru, P Petrossians, A Colao, et al.
Blood|August 15, 1997
Evidence that the RHD(VI) deletion genotype does not existP A Maaskant-van Wijk, E A Beckers, D J van Rhenen, et al.
Pageof 26

Showing results (231-240 of 255) with videos related to

Sort By:
Pageof 26
Clinical Endocrinology|December 24, 1997
Two years of replacement therapy in adults with growth hormone deficiencyJ Verhelst, R Abs, M Vandeweghe, et al.
Journal of the Neurological Sciences|March 1, 1992
The association of astrocytoma and pituitary adenoma in a patient with alcaptonuriaR Abs, M Van Vyve, P J Willems, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 23, 2016
GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone DeficiencyF Castinetti, A F Daly, C A Stratakis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patientsJ Verhelst, R Abs, D Maiter, et al.
Transfusion|December 2, 2017
The development of D antibodies after D-mismatched kidney transplantation in a setting of reduced immunosuppressionThomas H P M Habets, Joris Vanderlocht, Ron J M H E Straat, et al.
Clinical Endocrinology|April 18, 2003
Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiencyJ Svensson, J P Monson, T Vetter, et al.
Endocrine|April 26, 2020
The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) studyE C Coopmans, A Muhammad, A F Daly, et al.
Annales D'Endocrinologie|April 7, 2009
French consensus on the management of acromegalyP Chanson, J Bertherat, A Beckers, et al.
Endocrine|June 21, 2020
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey databaseV Amodru, P Petrossians, A Colao, et al.
Blood|August 15, 1997
Evidence that the RHD(VI) deletion genotype does not existP A Maaskant-van Wijk, E A Beckers, D J van Rhenen, et al.
Pageof 26